"acetylation of PYCR1 at K228 inhibits cell proliferation while deacetylation of PYCR1 mediated by SIRT3 increases PYCR1's activity. Our findings on the regulation of PYCR1 linked proline metabolism with SIRT3 CBP and cell growth thus providing a potential approach for cancer therapy."xsd:string